2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 212.290 | 168.690 | 92.643 | 189.113 | 201.010 | 222.754 | 580.503 | 660.372 | 886.100 | 1.257.369 |
Total Income - EUR | 231.560 | 213.825 | 112.258 | 200.833 | 250.877 | 286.498 | 601.180 | 735.130 | 956.335 | 1.349.802 |
Total Expenses - EUR | 224.998 | 181.146 | 133.658 | 216.285 | 217.094 | 222.399 | 516.807 | 740.070 | 854.464 | 1.144.383 |
Gross Profit/Loss - EUR | 6.562 | 32.679 | -21.400 | -15.452 | 33.783 | 64.099 | 84.373 | -4.940 | 101.872 | 205.419 |
Net Profit/Loss - EUR | 5.098 | 27.039 | -21.400 | -18.162 | 31.280 | 61.240 | 78.633 | -11.383 | 92.850 | 191.942 |
Employees | 2 | 3 | 2 | 4 | 2 | 2 | 4 | 6 | 8 | 10 |
Check the financial reports for the company - Ecripam S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 18.672 | 33.246 | 41.192 | 58.330 | 33.975 | 94.512 | 163.872 | 122.634 | 217.830 | 246.601 |
Current Assets | 69.406 | 63.107 | 25.508 | 34.244 | 55.318 | 101.291 | 238.267 | 208.815 | 214.941 | 500.365 |
Inventories | 940 | 0 | 0 | 0 | 450 | 441 | 0 | 0 | 0 | 0 |
Receivables | 37.259 | 14.858 | 10.939 | 28.189 | 46.062 | 79.996 | 228.694 | 173.026 | 180.845 | 424.762 |
Cash | 31.207 | 48.249 | 14.569 | 6.055 | 8.806 | 20.854 | 9.573 | 35.790 | 34.096 | 75.603 |
Shareholders Funds | 52.877 | 80.358 | 47.005 | 28.047 | 58.813 | 118.918 | 195.297 | 179.583 | 272.990 | 464.104 |
Social Capital | 89 | 90 | 89 | 88 | 86 | 89 | 87 | 85 | 85 | 85 |
Debts | 35.200 | 15.995 | 19.696 | 64.526 | 30.480 | 76.885 | 206.843 | 151.866 | 159.781 | 282.862 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4941 - 4941" | |||||||||
CAEN Financial Year |
4941
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ecripam S.r.l.